# Commission Implementing Regulation (EU) 2018/670 of 30 April 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bromuconazole, buprofezin, haloxyfop-P and napropamide (Text with EEA relevance), Signature

Extent: E+W+S+N.I.

This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 30 April 2018.
For the Commission
The President
Jean-Claude Juncker

---
Source: https://www.legislation.gov.uk/eur/2018/670/signature (the official version)
Page: https://openlegislation.uk/eu-regulation-2018-670/signature
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.